Improvements in the Tolerability Profile of 2′-O-Methoxyethyl Chimeric Antisense Oligonucleotides in Parallel with Advances in Design, Screening, and Other Methods
出版年份 2021 全文链接
标题
Improvements in the Tolerability Profile of 2′-O-Methoxyethyl Chimeric Antisense Oligonucleotides in Parallel with Advances in Design, Screening, and Other Methods
作者
关键词
-
出版物
Nucleic Acid Therapeutics
Volume -, Issue -, Pages -
出版商
Mary Ann Liebert Inc
发表日期
2021-07-10
DOI
10.1089/nat.2020.0917
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Antisense technology: an overview and prospectus
- (2021) Stanley T. Crooke et al. NATURE REVIEWS DRUG DISCOVERY
- Lipoprotein(a) Reduction in Persons with Cardiovascular Disease
- (2020) Sotirios Tsimikas et al. NEW ENGLAND JOURNAL OF MEDICINE
- Antisense Drug Discovery and Development Technology Considered in a Pharmacological Context
- (2020) Stanley T. Crooke et al. BIOCHEMICAL PHARMACOLOGY
- Antisense Inhibition of Prekallikrein to Control Hereditary Angioedema
- (2020) Danny M. Cohn et al. NEW ENGLAND JOURNAL OF MEDICINE
- Ligand conjugated antisense oligonucleotide for the treatment of transthyretin amyloidosis: preclinical and phase 1 data
- (2020) Nicholas J. Viney et al. ESC Heart Failure
- Injection site reactions with the use of biological agents
- (2019) Elena Thomaidou et al. Dermatologic Therapy
- N-acetyl galactosamine-conjugated antisense drug to APOC3 mRNA, triglycerides and atherogenic lipoprotein levels
- (2019) Veronica J Alexander et al. EUROPEAN HEART JOURNAL
- Pharmacokinetics and Clinical Pharmacology Considerations of GalNAc3-Conjugated Antisense Oligonucleotides
- (2019) Yanfeng Wang et al. Expert Opinion on Drug Metabolism & Toxicology
- RNA-Targeted Therapeutics
- (2018) Stanley T. Crooke et al. Cell Metabolism
- Antisense Inhibition of Protein Tyrosine Phosphatase 1B With IONIS-PTP-1B Rx Improves Insulin Sensitivity and Reduces Weight in Overweight Patients With Type 2 Diabetes
- (2018) Andres Digenio et al. DIABETES CARE
- The Effects of 2′-O-Methoxyethyl Oligonucleotides on Renal Function in Humans
- (2018) Stanley T. Crooke et al. Nucleic Acid Therapeutics
- Injection site reactions after long-term subcutaneous delivery of drisapersen: a retrospective study
- (2018) Niels Hilhorst et al. EUROPEAN JOURNAL OF PEDIATRICS
- Injectability as a function of viscosity and dosing materials for subcutaneous administration
- (2018) Russell P. Watt et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Integrated Assessment of the Clinical Performance of GalNAc3-Conjugated 2′-O-Methoxyethyl Chimeric Antisense Oligonucleotides: I. Human Volunteer Experience
- (2018) Stanley T. Crooke et al. Nucleic Acid Therapeutics
- The Distinct and Cooperative Roles of Toll-Like Receptor 9 and Receptor for Advanced Glycation End Products in Modulating In Vivo Inflammatory Responses to Select CpG and Non-CpG Oligonucleotides
- (2017) Suzanne Paz et al. Nucleic Acid Therapeutics
- The Effects of 2′-O-Methoxyethyl Containing Antisense Oligonucleotides on Platelets in Human Clinical Trials
- (2017) Stanley T. Crooke et al. Nucleic Acid Therapeutics
- Antisense oligonucleotides targeting apolipoprotein(a) in people with raised lipoprotein(a): two randomised, double-blind, placebo-controlled, dose-ranging trials
- (2016) Nicholas J Viney et al. LANCET
- Integrated Safety Assessment of 2′-O-Methoxyethyl Chimeric Antisense Oligonucleotides in NonHuman Primates and Healthy Human Volunteers
- (2016) Stanley T Crooke et al. MOLECULAR THERAPY
- Changes in Mipomersen Dosing Regimen Provide Similar Exposure With Improved Tolerability in Randomized Placebo‐Controlled Study of Healthy Volunteers
- (2014) JoAnn D. Flaim et al. Journal of the American Heart Association
- Efficacy and safety of mipomersen sodium (Kynamro)
- (2013) Kees Hovingh et al. Expert Opinion On Drug Safety
- A Monte Carlo permutation test for co-occurrence data
- (2012) Balázs Kovács QUALITY & QUANTITY
- Predictivity of animal studies for human injection site reactions with parenteral drug products
- (2008) Jeffery A. Engelhardt EXPERIMENTAL AND TOXICOLOGIC PATHOLOGY
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started